|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/28 | (2006.01) | ||
| A61K 31/155 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Number of the document | 2707015 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12721268.6 |
| Date of filing the European patent application | 2012-05-11 | |
| (97) | Date of publication of the European application | 2014-03-19 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-09 |
| (46) | Date of publication of the claims translation | 2017-02-27 |
| (86) | Number | PCT/EP2012/058749 |
| Date | 2012-05-11 |
| (87) | Number | WO 2012/156299 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 11166111 | 2011-05-13 | EP |
| (72) |
NIEMÖLLER, Elisabeth, DE
SILVESTRE, Louise, FR
BOKA, Gabor, FR
MIOSSEC, Patrick, FR
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Liksisenatidas kaip papildoma bazaliniam insulinui terapija, esant 2 tipo diabetui |
| LIXISENATIDE AS ADD-ON THERAPY TO BASAL INSULIN IN TYPE 2 DIABETES |
| Payment date | Validity (years) | Amount | |
| 2019-04-12 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-05-11 |